The new versus the old: local anaesthesia techniques examined

Article

A survey of British Ophthalmologists has found that there is a lower rate of serious complications after cataract surgery if sub–Tenon's, topical and topical–intracameral local anaesthesias are used rather than the "older" retrobulbar and peribulbar techniques.

A survey of British Ophthalmologists has found that there is a lower rate of serious complications after cataract surgery if sub–Tenon's, topical and topical–intracameral local anaesthesias are used rather than the 'older' retrobulbar and peribulbar techniques.

Tom Eke of the Norfolk & Norwich University Hospital and John Thompson from the University of Leicester, UK, conducted a prospective, observational study of routine practice in the UK for 13 months during the 2002 - 2003 period. The study was done through the British Ophthalmic Surveillance Unit (BOSU). Each month BOSU contacted all senior UK ophthalmologists asking for recent cases of 'potentially sight–threatening or life threatening complications of local anaesthesia for cataract surgery'.

The results showed that cataract surgery, conducted within the National Health Service (NHS), comprised 4.1% under general anaesthesia, 92.1% with local anaesthesia without sedation and 2.9% with local anaesthesia and sedation. Approximately 375,000 local anaesthesias were given for cataract surgery during the survey period. Of these, 30.6% used the peribulbar technique, 3.5% retrobulbar, 42.6% sub–Tenon's, 1.7% sub–conjunctival, 9.9% topical and 11% topical–intracameral local anaesthesia.

The largest number of potentially sight–threatening complications were reported in association with the retrobulbar and peribulbar technique. Twenty–six cases of globe penetration or perforation, 16 of which resulted in a poor visual outcome, were reported. Potentially life–threatening complications were reported with all techniques except for topical and intracameral local anaesthesias. Eight neurological complications were reported, seven of which occurred after peribulbar or retrobulbar anaesthesia.

The authors believe that the study demonstrates that newer techniques, such as sub–Tenon's, topical and topical–intracameral anaesthesia, offer a more favourable safety profile than more traditional methods.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.